1997
DOI: 10.1007/s002510050316
|View full text |Cite
|
Sign up to set email alerts
|

An antibody specific for Tcrb-V10a and Tcrb-V10c

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1998
1998
1999
1999

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…The following mAb were used: B20.6 (anti-V g 2); KJ25 (anti-V g 3.1); KJ23 (anti-V g 3.2); KT4-10 (anti-V g 4); MR9-4 (anti-V g 5.1-2); 44.22.1 (anti-V g 6); TR310 (anti-V g 7); F23.2 (anti-V g 8.2); KJ16 (anti-V g 8.1-2); F23.1 (anti-V g 8.1-3); MR10-2 (anti-V g 9); B21.5 (anti-V g 10 b ), KT10a (anti-V g 10 a/c ) [41]; RR3-15 (anti-V g 11); MR11-1 (anti-V g 12); 14.2 (anti-V g 14); FITC-labeled anti-B220 (RA3-3A1), PE-labeled anti-CD4 (H129. 19) and anti-CD8 (53-6.7) (Caltag laboratories, San Francisco, CA).…”
Section: Monoclonal Antibodiesmentioning
confidence: 99%
“…The following mAb were used: B20.6 (anti-V g 2); KJ25 (anti-V g 3.1); KJ23 (anti-V g 3.2); KT4-10 (anti-V g 4); MR9-4 (anti-V g 5.1-2); 44.22.1 (anti-V g 6); TR310 (anti-V g 7); F23.2 (anti-V g 8.2); KJ16 (anti-V g 8.1-2); F23.1 (anti-V g 8.1-3); MR10-2 (anti-V g 9); B21.5 (anti-V g 10 b ), KT10a (anti-V g 10 a/c ) [41]; RR3-15 (anti-V g 11); MR11-1 (anti-V g 12); 14.2 (anti-V g 14); FITC-labeled anti-B220 (RA3-3A1), PE-labeled anti-CD4 (H129. 19) and anti-CD8 (53-6.7) (Caltag laboratories, San Francisco, CA).…”
Section: Monoclonal Antibodiesmentioning
confidence: 99%